The formula reader
Keep the claim and its limits together.
Read four parts of a face-cream record: its everyday role, percentage, study setting and package identity. Each record keeps a documented fact beside the evidence boundary, an unresolved detail and a question for the relevant professional.
These are fixed reading examples, not a skin assessment or a product-selection tool. They do not provide a routine, compatibility decision or instructions for treated skin. Facework is part of CoreAge Rx’s promotional publishing network; its commercial placement does not establish clinical superiority.
A cream’s everyday role
- Documented fact
AAD guidance discusses moisturization for dryness associated with menopause. The Ordinary and NIOD identify their reviewed products as water-based serums; Bounce Back mainly describes a cream.
- Evidence boundary
General moisturizer guidance does not measure the firming effect of these products. A cream or serum description alone does not establish hydration, tolerance or peptide delivery for the finished formula.
- Unresolved
Bounce Back’s complete base is not established in the reviewed public offer, and its pricing bullets use serum wording. The exact supplied form still needs clarification.
- A question for the professional
What is the complete preparation being discussed, and which of its claimed benefits concern moisturization rather than a separately measured treatment outcome?
The meaning of the printed percentage
- Documented fact
CoreAge advertises copper peptide at 2%. NIOD separately describes 1% GHK-Cu and 1% GHK in CAIS; those two components are not two identical copper-peptide portions.
- Evidence boundary
A printed figure is a product claim, not an independent assay. Different ingredient descriptions do not establish a shared percentage basis or a clinical potency comparison.
- Unresolved
The reviewed Bounce Back record does not establish the exact analytical definition of its 2%, including whether it represents a specified GHK-Cu measurement in the supplied preparation.
- A question for the professional
Which ingredient specification and finished-preparation document explain exactly what this percentage refers to?
The setting of the copper study
- Documented fact
The original CO₂-laser study abstract reports 13 completers. Objective comparisons did not show a significant group advantage, while a questionnaire finding favored the GHK-Cu regimen.
- Evidence boundary
This was a specific post-procedure setting, not proof of routine Bounce Back results. The reviewed abstract does not establish a matching finished formula or authorize use after another procedure.
- Unresolved
The full study report was not verified here. Whether a particular preparation belongs in a person’s aftercare plan remains a question for the treating professional.
- A question for the professional
Does this exact product belong in the procedure team’s written plan, and what product information would the team need to answer that question?
The item behind the offer
- Documented fact
Bounce Back’s public offer describes one- and three-month plans. A plan period is different from a container’s net contents, container count or complete ingredient record.
- Evidence boundary
Neither a price display nor a package image verifies the contents of a dispensed preparation. FDA’s cosmetic labeling framework is not a substitute for identifying the actual compounded product and its pharmacy record.
- Unresolved
The reviewed offer does not settle the supplied quantity, complete formula or preparation-specific handling information. No container or completed transaction was inspected.
- A question for the professional
Can the provider and dispensing pharmacy identify the exact form, contents, quantity and written information that would accompany this preparation?